Table 2. Functional and anatomical outcomes.
P-value | ||
---|---|---|
BCVA baseline, logMAR, mean ± SD | 0.66 ± 0.14 | |
BCVA 1 month, logMAR, mean ± SD | 0.54 ± 0.18 | <0.001 |
BCVA 6 month, logMAR, mean ± SD | 0.52 ± 0.20 | <0.001 |
BCVA 12 month, logMAR, mean ± SD | 0.52 ± 0.21 | <0.001 |
BCVA 24 month, logMAR, mean ± SD | 0.53 ± 0.22 | <0.001 |
CST baseline, μm, mean ± SD | 600 ± 83 | |
CST 1 month, μm, mean ± SD | 260 ± 33 | <0.001 |
CST 6 month, μm, mean ± SD | 240 ± 34 | <0.001 |
CST 12 month, μm, mean ± SD | 236 ± 31 | <0.001 |
CST 24 month, μm, mean ± SD | 230 ± 30 | <0.001 |
BCVA—best corrected visual acuity; CST—central subfoveal thickness; SD—standard deviation; P-value—compared to baseline measurement.